Eli Lilly & Co. (LLY)
Health Care ยท Pharmaceutical Preparations
Eli Lilly & Co. (LLY) is listed on the New York Stock Exchange, where its shares have traded since July 9, 1970. SentiSense covers Eli Lilly & Co. in the Health Care sector, and its Standard Industrial Classification is Pharmaceutical Preparations. David A. Ricks is its chief executive officer. The company reports 50,000 employees, and its corporate website is www.lilly.com.
About Eli Lilly & Co.
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Latest reported results
Eli Lilly and Company reported revenue of $24.40 billion for Q3 FY2026, up 38.6% from the same period a year earlier.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 4,597 institutions reported holding LLY, with 781.5 million shares worth $935.5 billion in aggregate. The largest reported holders were Lilly Endowment, Vanguard and BlackRock. Of the 5 largest reported holders, 2 added shares and 3 reduced their positions during the quarter.
More on LLY
- LLY sentiment: whether news and social coverage of Eli Lilly & Co. leans bullish or bearish, and the stories driving it.
- LLY ownership: all 4,597 reporting institutions, plus insider and congressional trades.
- LLY financials: revenue, net income, operating margin and free cash flow through Q3 FY2026.
SentiSense also tracks daily options readings for Eli Lilly & Co.: IV rank, put/call percentile, 25-delta skew and open-interest walls.
Frequently asked questions
What does Eli Lilly & Co. do?
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology.
What sector is LLY in?
SentiSense classifies Eli Lilly & Co. in the Health Care sector, and its Standard Industrial Classification is Pharmaceutical Preparations.
Where does LLY stock trade?
Eli Lilly & Co. (LLY) is listed on the New York Stock Exchange, where its shares have traded since July 9, 1970.
Who is the CEO of Eli Lilly & Co.?
David A. Ricks is the chief executive officer of Eli Lilly & Co..